GO:0031012 extracellular matrix: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031012 extracellular matrix is a cellular component defined as a structure lying external to one or more cells that provides structural support and biochemical or biomechanical cues for cells or tissues.
• The extracellular matrix is composed of a complex network of proteins and polysaccharides, including collagens, proteoglycans, glycoproteins, and elastin, which together form the matrisome.
• ECM remodeling is critical in vascular homeostasis and disease, with dynamic changes in composition and stiffness influencing cell behavior.
• ECM-cell interactions are mediated by integrins and other receptors, transmitting signals that regulate proliferation, migration, and differentiation.
• Dysregulated ECM is a hallmark of cancer, atherosclerosis, and fibrosis, making it a promising therapeutic target.
• CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, enable precise dissection of ECM gene function in health and disease.
Description
The extracellular matrix (ECM) is a fundamental component of all multicellular organisms, providing not only structural scaffolding but also critical biochemical and biomechanical signals that regulate cell behavior. As defined by the Gene Ontology, the ECM is a structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues (GO:0031012). The ECM is highly dynamic and tissue-specific, composed of a diverse array of proteins and polysaccharides that are collectively termed the matrisome. Understanding the ECM is essential for researchers across developmental biology, cancer biology, cardiovascular research, and tissue engineering, as its dysregulation underlies numerous pathological conditions. Recent advances in proteomics, imaging, and genome editing have accelerated the discovery of ECM components and their functions, making it a vibrant area of biomedical research.
extracellular matrix At A Glance
| GO ID | GO:0031012 |
|---|---|
| GO term | extracellular matrix |
| Ontology | cellular_component |
| Synonym | matrisome, proteinaceous extracellular matrix |
| Major function | Provides structural support and biochemical/biomechanical cues for cells or tissues |
| Composition | Collagens, proteoglycans, glycoproteins, elastin, fibronectin, laminins, and other matrix proteins |
| Key regulators | Integrins, growth factors, matrix metalloproteinases (MMPs), and crosslinking enzymes |
| Associated diseases | Cancer, atherosclerosis, fibrosis, and vascular remodeling |
What Is GO:0031012?
The extracellular matrix (GO:0031012) is a structure that lies external to one or more cells and provides structural support as well as biochemical or biomechanical cues for cells or tissues. It is a complex, dynamic network of proteins and polysaccharides that surrounds cells and is essential for tissue architecture, cell signaling, and mechanical properties.
Why Is extracellular matrix Important in Cell Biology?
The extracellular matrix is not merely a passive scaffold but an active participant in virtually every aspect of cell and tissue physiology. It provides mechanical support, regulates cell adhesion, migration, proliferation, and differentiation, and serves as a reservoir for growth factors and signaling molecules. ECM remodeling is essential during development, wound healing, and tissue homeostasis, and its dysregulation contributes to a wide range of diseases, including cancer, cardiovascular disease, and fibrosis. Therefore, understanding ECM composition, assembly, and function is critical for both basic biology and translational medicine.
• Provides structural integrity and mechanical properties to tissues and organs.
• Regulates cell behavior through biochemical and biomechanical signaling.
• Serves as a reservoir for growth factors and cytokines, modulating their availability and activity.
• Plays a central role in vascular homeostasis and remodeling, with implications for hypertension and atherosclerosis.
• Dysregulated ECM promotes tumor progression, invasion, and metastasis.
• ECM stiffness and composition influence stem cell differentiation and tissue regeneration.
• Genetic mutations in ECM genes cause connective tissue disorders and cardiovascular diseases.
• ECM components are promising biomarkers and therapeutic targets in cancer and fibrosis.
• Advanced imaging and proteomics enable detailed mapping of the matrisome in health and disease.
• CRISPR screening identifies ECM genes essential for cell adhesion, migration, and drug resistance.
What Happens During extracellular matrix?
ECM Synthesis and Secretion
In simple terms: Cells produce and release matrix proteins to build the ECM around them.
ECM components such as collagens, proteoglycans, and glycoproteins are synthesized in the endoplasmic reticulum and Golgi apparatus and then secreted into the extracellular space. This process is tightly regulated by transcriptional and post-translational mechanisms, including glycosylation and propeptide cleavage. For example, collagen fibrils assemble after secretion and are stabilized by crosslinking enzymes like lysyl oxidase.
ECM Assembly and Crosslinking
In simple terms: Secreted matrix proteins assemble into organized networks and are chemically crosslinked for stability.
After secretion, ECM proteins self-assemble or are assembled by cell-mediated processes into supramolecular structures such as collagen fibrils, elastin fibers, and basement membranes. Crosslinking by transglutaminases and lysyl oxidases enhances tensile strength and protease resistance. Proteoglycans and glycoproteins like fibronectin and laminin provide organizational cues and cell-binding sites.
ECM Remodeling and Degradation
In simple terms: The ECM is constantly broken down and rebuilt, allowing tissue remodeling and repair.
Matrix metalloproteinases (MMPs) and other proteases degrade ECM components, releasing bioactive fragments and growth factors. This remodeling is essential for development, wound healing, and angiogenesis, but excessive degradation contributes to pathological tissue destruction. Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity to maintain homeostasis.
ECM-Cell Signaling
In simple terms: Cells sense the ECM through receptors and respond by changing their behavior.
Integrins and other cell surface receptors bind to ECM ligands and transmit signals that regulate cytoskeletal organization, gene expression, and cell fate. Mechanotransduction pathways convert mechanical cues from the ECM into biochemical signals, influencing processes such as proliferation, migration, and differentiation. Dysregulated ECM-cell signaling is a hallmark of cancer and fibrosis.
Key Genes Involved in GO:0031012 extracellular matrix
The following genes encode core ECM components and regulators that are frequently studied in matrix biology and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Fibrillar collagen, major component of bone, skin, and tendon | Mutations cause osteogenesis imperfecta; target in fibrosis and cancer |
| COL4A1 | Basement membrane collagen | Mutations linked to vascular and renal disease; studied in angiogenesis |
| FN1 | Fibronectin, adhesive glycoprotein | Essential for cell adhesion, migration, and wound healing; implicated in cancer |
| LAMA1 | Laminin subunit, basement membrane component | Regulates cell polarity and differentiation; role in muscular dystrophy |
| ELN | Elastin, provides elasticity to tissues | Mutations cause supravalvular aortic stenosis; studied in vascular remodeling |
| MMP2 | Matrix metalloproteinase-2, degrades collagen IV and gelatin | Promotes tumor invasion and angiogenesis; target in cancer |
| MMP9 | Matrix metalloproteinase-9, degrades collagen IV and elastin | Involved in inflammation and vascular remodeling |
| TIMP1 | Inhibitor of MMPs | Regulates ECM turnover; dysregulated in fibrosis and cancer |
| ITGB1 | Integrin beta-1, ECM receptor | Mediates cell-ECM adhesion and signaling; essential for development |
| ITGA5 | Integrin alpha-5, fibronectin receptor | Regulates cell migration and proliferation; target in cancer |
| LOX | Lysyl oxidase, crosslinks collagen and elastin | Critical for ECM stability; promotes metastasis in cancer |
| SPARC | Matricellular protein, regulates ECM assembly | Modulates cell-ECM interactions; implicated in cancer and fibrosis |
| TGFB1 | Growth factor stored in ECM, regulates ECM synthesis | Drives fibrosis and cancer progression; therapeutic target |
| CTGF | Connective tissue growth factor, promotes ECM production | Key mediator of fibrosis; studied in vascular disease |
| ADAMTS1 | Protease that cleaves proteoglycans | Regulates ECM turnover and angiogenesis |
| HSPG2 | Perlecan, basement membrane proteoglycan | Essential for basement membrane integrity; role in development |
How Is extracellular matrix Regulated?
ECM composition and assembly are regulated at multiple levels, including transcriptional control by growth factors and cytokines such as TGF-beta and CTGF. Post-translational modifications, including glycosylation, sulfation, and crosslinking, modulate ECM stability and function. Proteolytic activity of MMPs and their inhibitors (TIMPs) determines the balance between ECM synthesis and degradation. Mechanical forces from the cellular microenvironment also feedback to regulate ECM gene expression through mechanotransduction pathways. In vascular remodeling, dynamic changes in ECM are controlled by integrin signaling and inflammatory mediators.
extracellular matrix and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL1A1 | Osteogenesis imperfecta, fibrosis | Knockout or point mutation in mesenchymal stem cells; overexpression in fibroblasts |
| MMP2 | Cancer invasion, angiogenesis | Knockout in cancer cell lines; overexpression in endothelial cells |
| ELN | Supravalvular aortic stenosis, vascular remodeling | Knockout in vascular smooth muscle cells; knock-in of patient mutations |
| ITGB1 | Developmental defects, cancer | Conditional knockout in mouse models; point mutation in integrin-binding domain |
| TGFB1 | Fibrosis, cancer | Overexpression in hepatic stellate cells; knockout in T cells |
ECM in Cancer
The ECM undergoes extensive remodeling in cancer, promoting tumor growth, invasion, and metastasis. Increased deposition of collagens and fibronectin, elevated MMP activity, and crosslinking by LOX create a stiff, pro-tumorigenic microenvironment. ECM components also modulate immune cell infiltration and drug resistance, making them attractive therapeutic targets.
ECM in Cardiovascular Disease
Vascular ECM remodeling is central to atherosclerosis, hypertension, and aneurysm formation. Altered collagen and elastin content, increased MMP activity, and integrin-mediated signaling contribute to plaque instability and vessel stiffening. Targeting ECM remodeling pathways is a promising strategy for cardiovascular therapy.
ECM in Fibrosis
Fibrosis is characterized by excessive ECM deposition, leading to organ dysfunction. TGF-beta and CTGF drive myofibroblast activation and collagen production, while MMP-TIMP imbalance impairs matrix degradation. ECM-targeted therapies aim to inhibit synthesis or enhance degradation.
From extracellular matrix-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of COL1A1 affect ECM assembly? | CRISPR knockout in fibroblasts followed by immunofluorescence and proteomics |
| How does a point mutation in ELN alter vascular elasticity? | CRISPR point mutation knock-in in smooth muscle cells; biomechanical testing |
| Can tagged FN1 reveal ECM dynamics? | Knock-in of fluorescent tag (e.g., GFP) in FN1 locus; live-cell imaging |
| Does overexpression of MMP9 promote invasion? | CRISPR activation or lentiviral overexpression in cancer cells; invasion assays |
| Which ECM genes are essential for cell adhesion? | Genome-wide CRISPR knockout library screening with adhesion readout |
| How does TGFB1 regulate ECM gene expression? | Knockout of TGFB1 in fibroblasts; RNA-seq and ChIP-seq |
How to Study the extracellular matrix Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | ECM protein composition and abundance | Matrisome profiling in tissues and cell cultures |
| Immunofluorescence microscopy | ECM protein localization and structure | Visualizing collagen fibers, fibronectin, and laminin |
| Atomic force microscopy | Tissue stiffness and elasticity | Measuring ECM mechanical properties in health and disease |
| CRISPR knockout screening | Gene essentiality for ECM-related phenotypes | Identifying regulators of cell adhesion and migration |
| RNA-seq | Transcriptional profiles of ECM genes | Comparing ECM gene expression across conditions |
| Live-cell imaging | Dynamic ECM assembly and remodeling | Tracking fluorescently tagged ECM proteins |
| Biochemical crosslinking assays | Collagen and elastin crosslink content | Assessing ECM maturation and stability |
| Zymography | MMP enzymatic activity | Measuring ECM degradation capacity |
Proteomics and Matrisome Analysis
Mass spectrometry-based proteomics enables comprehensive characterization of ECM composition, including insoluble and crosslinked proteins. Decellularization followed by LC-MS/MS identifies core matrisome components and associated factors.
Imaging and Biomechanics
Confocal and electron microscopy visualize ECM architecture, while atomic force microscopy and rheology measure stiffness and elasticity. Live-cell imaging of fluorescently tagged ECM proteins reveals dynamic assembly and remodeling.
Genome Editing and Functional Screens
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of ECM genes to test their functions. Pooled CRISPR screens with ECM-related readouts identify genes required for cell adhesion, migration, or drug resistance.
Transcriptomics and Bioinformatics
RNA-seq and single-cell transcriptomics reveal ECM gene expression patterns across tissues and disease states. Bioinformatics tools integrate ECM gene signatures with clinical data to identify biomarkers and therapeutic targets.
How CRISPR Can Be Used to Study GO:0031012 extracellular matrix
Knockout
CRISPR knockout of ECM genes (e.g., COL1A1, FN1, MMP2) in cell lines or primary cells abolishes protein function, enabling assessment of loss-of-function phenotypes such as impaired matrix assembly, altered adhesion, or reduced invasion. Knockout models are also used in pooled screens to identify ECM regulators.
Point Mutation
CRISPR point mutation knock-in introduces specific disease-associated mutations (e.g., in ELN or COL4A1) to study their effects on ECM structure and function. This approach preserves endogenous expression levels and regulatory context, providing physiologically relevant models.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into ECM loci allows real-time visualization and biochemical isolation of ECM proteins. Knock-in of patient mutations or SNPs can model genetic susceptibility to ECM-related diseases.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of ECM genes (e.g., TGFB1, CTGF) drives excessive matrix production, modeling fibrosis or cancer-associated desmoplasia. Overexpression models are useful for gain-of-function studies and drug testing.
How EDITGENE Supports extracellular matrix Research
Researchers studying extracellular matrix-related genes often need to determine whether a candidate gene is causally involved in ECM assembly, remodeling, or disease pathogenesis. Precise genome editing tools are essential to establish these causal links and to develop reliable cellular models for mechanistic and therapeutic studies.
Contact EDITGENE today to design your custom CRISPR model for extracellular matrix research.
Frequently Asked Questions About extracellular matrix
What is the extracellular matrix GO:0031012?
GO:0031012 is the Gene Ontology term for the extracellular matrix, defined as a structure lying external to one or more cells that provides structural support and biochemical or biomechanical cues for cells or tissues.
What genes are involved in the extracellular matrix?
Key genes include collagens (e.g., COL1A1, COL4A1), fibronectin (FN1), laminins (LAMA1), elastin (ELN), MMPs (MMP2, MMP9), integrins (ITGB1, ITGA5), and growth factors like TGFB1.
What are the main components of the extracellular matrix?
The ECM is composed of collagens, proteoglycans, glycoproteins (fibronectin, laminin), elastin, and matricellular proteins, collectively known as the matrisome.
How is the extracellular matrix remodeled?
ECM remodeling involves synthesis, assembly, crosslinking, and degradation by MMPs, regulated by TIMPs and growth factors such as TGF-beta.
What diseases are associated with extracellular matrix dysfunction?
ECM dysregulation is linked to cancer, atherosclerosis, fibrosis, osteogenesis imperfecta, and vascular remodeling disorders.
How can CRISPR be used to study extracellular matrix genes?
CRISPR knockout, point mutation, knock-in, and overexpression enable precise manipulation of ECM genes to test their roles in matrix assembly, cell signaling, and disease.
What is the matrisome?
The matrisome is the collection of all ECM and ECM-associated proteins, including core matrix components and regulators.
How does the extracellular matrix affect cell behavior?
The ECM provides mechanical support and biochemical signals via integrins and other receptors, influencing proliferation, migration, differentiation, and survival.
What methods are used to study the extracellular matrix?
Common methods include proteomics, immunofluorescence, atomic force microscopy, CRISPR screens, RNA-seq, and live-cell imaging.
Why is the extracellular matrix important in cancer?
ECM remodeling promotes tumor growth, invasion, and metastasis, and contributes to drug resistance, making it a therapeutic target.
Conclusion
The extracellular matrix (GO:0031012) is a dynamic and essential component of all tissues, providing structural support and critical biochemical and biomechanical cues that regulate cell behavior. Its dysregulation is central to cancer, cardiovascular disease, and fibrosis, making it a high-priority area for basic and translational research. Advances in CRISPR genome editing, proteomics, and imaging now allow researchers to dissect ECM gene function with unprecedented precision. Understanding the ECM will continue to yield insights into tissue homeostasis and disease, and drive the development of novel therapeutics.
References
- 1. Theocharis AD et al.. 2016. Extracellular matrix structure.. Adv Drug Deliv Rev 97:4-27 PMID: 26562801
- 2. Zhang L et al.. 2025. Extracellular matrix in vascular homeostasis and disease.. Nat Rev Cardiol 22(5):333-353 PMID: 39743560
- 3. Fu Y et al.. 2024. Extracellular Matrix Interactome in Modulating Vascular Homeostasis and Remodeling.. Circ Res 134(7):931-949 PMID: 38547250
- 4. Frantz C et al.. 2010. The extracellular matrix at a glance.. J Cell Sci 123(Pt 24):4195-200 PMID: 21123617
- 5. Ma Z et al.. 2020. Extracellular matrix dynamics in vascular remodeling.. Am J Physiol Cell Physiol 319(3):C481-C499 PMID: 32579472
- 6. Di Nubila A et al.. 2024. Vascular Extracellular Matrix in Atherosclerosis.. Int J Mol Sci 25(22) PMID: 39596083
- 7. Sainio A et al.. 2020. Extracellular matrix-cell interactions: Focus on therapeutic applications.. Cell Signal 66:109487 PMID: 31778739
- 8. Chitty JL et al.. 2025. The extracellular matrix in cancer: from understanding to targeting.. Trends Cancer 11(9):839-849 PMID: 40467384
